Farkouh and associates investigated cardiovascular outcomes in high-risk patients with arthritis treated with ibuprofen, naproxen, or lumiracoxib.
Farkouh及其同事调查了患有关节炎的高危患者应用布洛芬、萘普生或氯美昔布治疗的心血管结果。
Farkouh and associates investigated cardiovascular outcomes in high-risk patients with arthritis treated with ibuprofen, naproxen, or lumiracoxib.
Farkouh及其同事调查了患有关节炎的高危患者应用布洛芬、萘普生或氯美昔布治疗的心血管结果。
应用推荐